106
Views
0
CrossRef citations to date
0
Altmetric
Review

Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data

Pages 181-189 | Published online: 01 Aug 2013

References

  • Joint United Nations Programme on HIV/AIDS (UNAIDS)Global Report: UNAIDS Report on the Global AIDS Epidemic – 2012GenevaUNAIDS2012 Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdfAccessed May 27, 2013
  • WettsteinCMugglinCEggerMSouthern Africa Collaboration. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysisAIDS201226182361237322948267
  • ConnorEMSperlingRSGelberRReduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupN Engl J Med199433118117311807935654
  • SperlingRSShapiroDEMcSherryGDSafety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 StudyAIDS19981214180518139792381
  • World Health OrganizationAntiretroviral therapy for HIV infection in adults and adolescentsRecommendations for a public health approach (2006 revision) Available from: whttp://www.who.int/hiv/pub/arv/adult/en/Accessed March 20, 2013
  • Orne-GliemannJBecquetREkoueviDKLeroyVPerezFDabisFChildren and HIV/AIDS: from research to policy and action in resource-limited settingsAIDS200822779780518427197
  • World Health Organization HIV/AIDS ProgramAntiretroviral drugs for treating pregnant women and preventing HIV infection in infants, 2010 version Available from: http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdfAccessed March 20, 2013
  • Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal TransmissionRecommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United StatesWashingtonDHHS2012 Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdfAccessed May 27, 2013
  • MirochnickMBestBMClarkeD FAntiretroviral pharmacology: special issues regarding pregnant women and neonatesClin Perinatol201037490792721078458
  • NewschafferCJCocroftJAndersonCEHauckW WTurnerBJPrenatal zidovudine use and congenital anomalies in a Medicaid populationJ Acquir Immune Defic Syndr200024324925610969349
  • The Antiretroviral Pregnancy Register2012 Available from: http://www.apregistry.com/forms/interim_report.pdfAccessed March 15, 2013
  • Correa-VillaseñorACraganJKucikJO’LearyLSiffelCWilliamsLThe Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and PreventionBirth Defects Res A Clin Mol Teratol200367961762414703783
  • NachmanSAChernoffMGonaPIncidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART eraArch Pediatr Adolesc Med2009163216417119188649
  • European Collaborative StudyThe mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the WestAIDS200620101419142716791017
  • SharlandMdi ZubGCRamosJTBlancheSGibbDMPENTA guidelines for the use of antiretroviral therapy in pediatric HIV infection. Pediatric European Network for Treatment of AIDSHIV Med20023321522612139662
  • ReadJSDuarteGHanceLFThe NICHD International Site Development Initiative perinatal cohorts (2002–2009)Int J Epidemiol201241364264921357185
  • WittKLCunninghamCKPattersonKBElevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIVEnviron Mol Mutagen2007483–432232917358032
  • WattsDHHuangSCulnaneMBirth defects among a cohort of infants born to HIV-infected women on antiretroviral medicationJ Perinat Med201139216317021142844
  • BorojerdiJ PMingJCoochCCentrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cellsMutat Res20096651–2677419427513
  • ThorneCNewellMLSafety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?Drug Saf200730320321317343429
  • MandelbrotLLandreau-MascaroARekacewiczCLamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1JAMA2001285162083209311311097
  • PatelDThorneCFioreSNewellMLDoes highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?J Acquir Immune Defic Syndr200540111611816123696
  • WattsDHLiDHandelsmanEAssessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission StudyJ Acquir Immune Defic Syndr200744329930517159659
  • TownsendCLCortina-BorjaMPeckhamCSTookeyPATrends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990–2006BJOG200811591078108618503577
  • JoaoECCalvetGAKraussMRMaternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal studyJ Acquir Immune Defic Syndr201053217618520104119
  • BroglySBAbzugMJWattsDHBirth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219CPediatr Infect Dis J201029872172720539252
  • WattsDHHuangSCulnaneMBirth defects among a cohort of infants born to HIV-infected women on antiretroviral medicationJ Perinat Med201139216317021142844
  • KnappKMBroglySBMuenzDGPrevalence of congenital anomalies in infants with in utero exposure to antiretroviralsPediatr Infect Dis J201231216417021983213
  • Nielsen-SainesKKomarowLCu-UvinSInfant outcomes after maternal antiretroviral exposure in resource-limited settings20121296e1525e1532
  • GibbDMKizitoHRussellECPregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trialPLoS Med201295e100121722615543
  • JeantilsVKhuongMADelassusJLEfavirenz (Sustiva) in pregnancy: a study about 12 HIV patientsGynecol Obstet Fertil20063478593596 French
  • FordNCalmyAMofensonLSafety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysisAIDS201125182301230421918421
  • De SantisMCarducciBDe SantisLCavaliereA FStrafaceGPericonceptional exposure to efavirenz and neural tube defectsArch Intern Med2002162335511822930
  • SaitohAHullADFranklinPSpectorSAMyelomeningocele in an infant with intrauterine exposure to efavirenzJ Perinatol200525855555616047034
  • ShanskeALBilateral oblique facial clefts and extremity anomaly in an infant after intrauterine efavirenz exposure and review of its teratogenic riskAIDS201226141775177922695300
  • EkoueviDKCoffePAOuattaraEPregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d’IvoireJ Acquir Immune Defic Syndr201156218318721084995
  • BeraEMcCauslandKNonkweloRMgudlwaBChackoSMajekeBBirth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospitalAIDS201024228328919864931
  • BussmannHWesterC WPregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in BotswanaJ Acquir Immune Defic Syndr200745326927317450102
  • HsuHERydzakCECotichKLQuantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the U S AHIV Med20111229710820561082
  • OuattaraENAnglaretXWongAYProjecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageAIDS201226562563422398569
  • SturtASDokuboEKSintTTAntiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenCochrane Database Syst Rev2010173CD00844020238370
  • HeidariSMofensonLCottonM FMarlinkRCahnPKatabiraEAntiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected childrenJ Acquir Immune Defic Syndr201157429029621602695
  • WattsDHWilliamsPLKacanekDCombination antiretroviral use and preterm birthJ Infect Dis2013207461262123204173
  • BaetenJMDonnellDNdasePAntiretroviral prophylaxis for HIV prevention in heterosexual men and womenN Engl J Med2012367539941022784037
  • Van DammeLCorneliAAhmedKPreexposure prophylaxis for HIV infection among African womenN Engl J Med2012367541142222784040
  • HernándezCMHIV/AIDS in childbearing Hispanic/Latinas: an emerging crisisMCN Am J Matern Child Nurs201136635435821918488
  • SanthyaKGEarly marriage and sexual and reproductive health vulnerabilities of young women: a synthesis of recent evidence from developing countriesCurr Opin Obstet Gynecol201123533433921836504
  • ShettyAKEpidemiology of HIV infection in women and children: a global perspectiveCurr HIV Res2013112819223432485
  • HartmanTLBuckheitRWJrThe continuing evolution of HIV-1 therapy: identifcation and development of novel antiretroviral agents targeting viral and cellular targetsMol Biol Int2012201240196522848825